soul trial oral semaglutide cardiovascular outcomes nejm 2025 results In patients with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization for heart failure or all-cause mortality compared to sitagliptin, but tirzepatide offered no additional benefit over semaglutide. #ESCCongress Cardiovascular Outcomes Associated with Semaglutide
Pay in 4 interest-free payments of $6.32 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7























![Goblin Elite Attack Force [BP01-EN140] Starfoil Rare XY190](https://cdn.shopify.com/s/files/1/0757/5211/2443/products/a6a8ca9e-89de-53db-977e-497075bc3c81.png?v=1683358167)



